Enlight: Pharmas Collaborate on Novel Start-up
This article was originally published in Start Up
Executive Summary
Merck, Lilly and Pfizer team up with PureTech Ventures to form Enlight Biosciences, a novel start-up developing next-generation technologies that promise to speed the way drugs are found and developed.
You may also be interested in...
JDRF, PureTech Try Nonprofit Ownership To Fill Funding Gap For Diabetes Tech
Call it venture philanthropy with a twist: If all goes as planned, the Juvenile Diabetes Research Foundation will co-own a series of companies dedicated to type 1 diabetes treatments without violating tax code, thanks to a structure created by Boston’s PureTech Ventures.
JDRF, PureTech Try Nonprofit Ownership To Fill Funding Gap
Call it venture philanthropy with a twist: if all goes to plan, the Juvenile Diabetes Research Foundation will co-own a series of biotech companies dedicated to type 1 diabetes treatments without violating tax code, thanks to a structure created by Boston’s PureTech Ventures.
VC Enlight Biosciences Signs Two New Members, Advances Portfolio Companies
Enlight has created a novel funding mechanism, in partnership with pharma members and academic networks, for technology sourcing and company creation.